Natural antimicrobials and their role in vaginal health: A short review

International Journal of Probiotics and Prebiotics

Volumn 3, Issue 4, 2008, Pages 219-230

  Dover, S E ^a,b   Aroutcheva, A A ^c,d   Faro, S ^e   Chikindas, M L ^b,d  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b RUTGERS UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Health Promoting Naturals Inc   (United States)

^e Women's Hospital of Texas   (United States)

Author keywords

Bacterial vaginosis; Bacteriocins; Lactic acid; Lactobacilli; Natural antimicrobials

Indexed keywords

ACIDFORM; ALUMINUM DERIVATIVE; AMPHORA; BACTERIOCIN; BACTERIOCIN HV219; CLINDAMYCIN; EDETIC ACID; ELLEN; HYDROGEN PEROXIDE; LACTACYD VAGINAL GEL; LACTAL; LACTATE SODIUM; LACTIC ACID; LACTOCIN 160; METRONIDAZOLE; MYCONIP; NISIN; PENTOCIN TV35B; PLACEBO; POLYCARBOPHIL; POLYLYSINE; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; USNIC ACID; VAGIFORTE; VSL3; ZINC DERIVATIVE; ZINC SULFATE;

ABSENCE OF SIDE EFFECTS; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL FLORA; CLINICAL TRIAL; DRUG POTENTIATION; DRUG SAFETY; GARDNERELLA VAGINALIS; GAS EMBOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LACTOBACILLUS; LOW BIRTH WEIGHT; NONHUMAN; PREMATURE LABOR; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SUBCUTANEOUS EMPHYSEMA; VAGINITIS;

EID: 60749120939     PISSN: 15551431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. 2 concentrations generated, in vitro, by isolated strains and the levels found in vaginal secretions of women with and without infection. Journal of Obstetrics and Gynecology 18, 63-67.
2. Andersch, B., Lindell, D., Dahlen, I., Brandberg, A. (1990) Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecologic and Obstetric Investigation 30, 114-119.
3. Antonio, M.A., Hillier, S.L. (2003) DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. Journal of Clinical Microbiology 41, 1881-1887.
4. Anukam, K.C., Osazuwa, E., Ahonkhai, I., Ngwu, M., Osemene, G.I., Bruce A.A., Reid G. (2006a) Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infection. 8, 1450-1454
5. Anukam, K.C., Osazuwa, E., Osemene, G.I., Ehigiagbe, F, Bruce, A.W., Reid, G. (2006b) Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection 8, 2772-2776.
6. Aranha, C., Gupta, S., Reddy, K.V. (2004) Contraceptive efficacy of antimicrobial peptide nisin: in vitro and in vivo studies. Contraception 69, 333-338.
7. Aroutcheva, A., Gariti, D., Simon, M., Shott, S., Faro, J., Simoes, J.A., Gurguis, A., Faro, S. (2001a) Defense factors of vaginal lactobacilli. American Journal of Obstetrics and Gynecology 185, 375-379.
8. Aroutcheva, A., Simoes, J.A., Shott, S., Faro, S. (2001b) The inhibitory effect of clindamycin on Lactobacillus in vitro. Infectious Diseases in Obstetrics and Gynecology 9, 239-244.
9. Aroutcheva, A., Simoes, J.A., Faro, S. (2001c) Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infectious Diseases in Obstetrics and Gynecology 9, 33-39.
10. Aslim, B., Kilic, E. (2006) Some probiotic properties of vaginal lactobacilli isolated from healthy women. Japanese Journal of Infectious Diseases 59, 249-253.
11. Atassi, F., Brassart, D., Grob, P., Graf, F., Servin, A.L. (2006) Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunology and Medical Microbiology 48, 424-432.
12. Avato, P, Bucci, R., Tava, A., Vitali, C., Rosato, A., Bialy, Z., Jurzysta, M. (2006) Antimicrobial activity of saponins from Medicago sp.: structure-activity relationship. Phytotherapy Research 20, 454-457.
13. Barnhart, K.T, Pretorius, E.S., Timbers, K., Shera, D., Shabbout, M., Malamud, D. (2004) In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception 70, 498-505.
14. Bioflora, December 12 2006: http://www.bioflora.co.za/vagiforte.htm
15. Boeke, A.J., Dekker, J.H., van Eijk, J.T, Kostense, PJ., Bezemer, P.D. (1993) Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. Genitourinary Medicine 69, 388-392.
16. Bonferoni, M.C., Giunchedi, P., Scalia, S., Rossi, S., Sandri, G., Caramella, C. (2006) Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSci Tech 7, 104.
17. Boris, J., Påhlson, C., Larsson, P. (1997) Six years observation after successful treatment of bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology 5, 297-302.
18. Boris, S., Suárez, J.E., Vázquez, F., Barbés, C. (1998) Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infection and Immunity 66, 1985-1989.
19. Boris, S., Barbés, C. (2000) Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes and Infection 2, 543-546.
20. Boskey, E.R., Cone, R.A., Whaley, K.J., Moench, T.R. (2001) Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Human Reproduction 16, 1809-1813.
21. Boskey, E.R. (2005) Alternative therapies for bacterial vaginosis: A literature review and acceptability survey. Alternative Therapies in Health and Medicine 11, 38-43.
22. Bourne, N., Stegall, R., Montano, R., Meador, M., Stanberry, L.R., Milligan, G.N. (2005) Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection. Antimicrobial Agents and Chemotherapy 49, 1181-1183.
23. Boziaris, I.S., Adams, M.R. (1999) Effect of chelators and nisin produced in situ on inhibition and inactivation of Gram-negatives. International Journal of Food Microbiology 53, 105-113.
24. Cardone, A., Zarcone, R., Borrelli, A., Di Cunzolo, A., Russo, A., Tartaglia, E. (2003) Utilisation of hydrogen peroxide in the treatment of recurrent bacterial vaginosis. Minerva Ginecologica 55, 483-492.
25. Cherpes, T.L., Meyn, L.A., Krohn, M.A., Hillier, S.L. (2003) Risk factors for infection with herpes simplex virus type 2: Role of smoking, douching, uncircumcised males, and vaginal flora. Sexually Transmitted Diseases 30, 405-410.
26. Cherrington, C.A., Hinton, M., Mead, G.C., Chopra, I. (1991) Organic acids: chemistry, antibacterial activity and practical applications. Advances in Microbial Physiology 32, 87-108.
27. Chvapil, M., Droegemueller, W., Betts, K., Heine, W., Weinstein, L. (1980) Preliminary testing of the contraceptive collagen sponge. Obstetrics & Gynecology 56, 503-506.
28. Cina, S.J., Downs, J.C.U., Conradi, S.E. (1994) Hydrogen peroxide: a source of lethal oxygen embolism. American Journal of Forensic Medicine and Pathology 15, 44-50.
29. Cohen, C.R., Duerr, A., Pruithithada, N., Rugpao, S., Hillier, S., Garcia, P., Nelson, K. (1995) Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9, 1093-1097.
30. Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L. (2001) Bacteriocins: safe, natural antimicrobials for food preservation. International Journal of Food Microbiology 71, 1-20.
31. Colodner, R., Edelstein, H., Chazan, B., Raz, R. (2003) Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Israeli Medical Association Journal 5, 767-769.
32. Decena, D.C.D., Co, J.T., Manalastras, R.M., Palaypayon, E.P., Padolina, C.S., Sison, J.M., Dancel, L.A., Lelis, M.A. (2006) Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. Journal of Obstetrics and Gynaecology Research 32, 243-251.
33. Delia, A., Morgante, G., Rago, G., Mustacchio, M.C., Petraglia, F., De Leo, V. (2006) Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Minerva Ginecologica 58, 227-231.
34. Diep, D.B., Nes, I.F. (2002) Ribosomally synthesized antibacterial peptides in Gram-positive bacteria. Current Drug Targets 3, 107-122.
35. Dover, S., Aroutcheva, A., Faro, S., Chikindas, M.L. (2007) Safety study of antimicrobial peptide Lactocin 160, produced by vaginal Lactobacillus rhamnosus. Infectious Diseases in Obstetrics and Gynecology Article ID: 78248
36. Ellen AB December 5, 2006: http://www.ellenab.com/index_eng.htm
37. Eriksson, K., Carlsson, B., Forsum, U., Larsson, P.G. (2005) A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Dermato-Venereologica 85, 42-46.
38. Ferris, D.G., Litaker, M.S., Woodward, L., Mathis, D., Hendrich, J. (1995) Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. Journal of Family Practice 41, 443-449.
39. Flynn, C.A., Helwig, A.L., Meurer, L.N. (1999) Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis. Journal of Family Practice 48, 885-892.
40. Fontaine, E.A., Taylor-Robinson, D. (1990) Comparison of quantitative and qualitative methods of detecting hydrogen peroxide produced by human vaginal strains of lactobacilli. The Journal of Applied Bacteriology 69, 326-331.
41. Forrer, J.A., Woods, W. (1997) Potential hazards of hydrogen peroxide within closed body cavities. The International Journal of STD & AIDS 8, 210.
42. Francis, G., Kerem, Z., Makkar, H.P.S., Becker, K. (2002) The biological action of saponins in animal systems: a review. The British Journal of Nutrition 88, 587-605.
43. Grether, J.K., Nelson, K.B. (2000) Possible decrease in prevalence of cerebral palsy in premature infants? The Journal of Pediatrics 136, 133.
44. Hashemi, F.B., Ghassemi. M, Roebuck, K.A., Spear, G.T. (1999) Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. The Journal of Infectious Diseases 179, 924-930.
45. Hashemi, F.B., Ghassemi, M., Faro, S., Aroutcheva, A., Spear, G.T. (2000) Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. The Journal of Infectious Diseases 181, 1574-1580.
46. Hay, P.E., Morgan, D.J., Ison, C.A., Bhide, S.A., Romney, M., McKenzie, P., Pearson, J., Lamont, R.F., Taylor-Robinson, D. (1994) A longitudinal study of bacterial vaginosis during pregnancy. British Journal of Obstetrics and Gynecology 101, 1048-1053.
47. Hay, P.E. (2004) Bacterial vaginosis and miscarriage. Current Opinion in Infectious Diseases 17, 41-44.
48. Hawes, S.E., Hillier, S.L., Benedetti, J., Stevens, C.E., Koutsky, L.A., Wolner-Hanssen, P., Holmes K.K. (1996) Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. Journal Of Infectious Diseases 174, 1058-1063.
49. Hill, J.A., Anderson, D.J. (1992) Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. American Journal of Obstetrics and Gynecology 166, 720-726.
50. Hill, G.B. (1993) The microbiology of bacterial vaginosis. American Journal of Obstetrics and Gynecology 169, 450-454.
51. Hillier, S.L., Krohn, M.A., Klebanoff, S.J., Eschenbach, D.A. (1992) The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstetrics & Gynecology 79, 369-373.
52. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clinical Infectious Diseases 16, S273-281.
53. Hillier, S.L, Nugent, R.P., Eschenbach, D.A., Krohn, M.A., Gibbs, R.S., Martin, D.H., Cotch, M.F., Edelman, R., Pastorek, J.G., Rao, A.V., McNellis, D., Regan, J.A., Carey, J.C., Klebanoff, M.A. (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The New England Journal of Medicine 333, 1737-1742.
54. Hiraki, J., Ichikawa, T., Ninomiya, S., Seki, H., Uohama, K., Seki, H., Kimura, S., Yanagimoto, Y., Barnett J.W. (2003) Use of ADME studies to confirm the safety of -̇poly-lysine as a preservative in food. Regulatory Toxicology and Pharmacology 37, 328-340.
55. Immucell April 23 2007: http://www.immucell.com/prods_mat.php#wipe
56. Itoh, T., Fujimoto, Y., Kawai, Y., Toba, T., Saito, T. (1995) Inhibition of food-borne pathogenic bacteria by bacteriocins from Lactobacillus gasseri. Letters in Applied Microbiology 21, 137-141.
57. Kawai, Y., Saito, T., Toba, T., Samant, S.K., Itoh, T. (1994) Isolation and characterization of a highly hydrophobic new bacteriocin (gassericin A) from Lactobacillus gasseri LA39. Bioscience Biotechnology & Biochemistry 58, 1218-1221.
58. Kaewsrichan, J., Peeyananjarassri, K., Kongprasertkit, J. (2006) Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunology and Medical Microbiology 48, 75-83.
59. Kaminsky, M., Willigan, D.A. (1982) pH and the potential irritancy of douche formulations to the vaginal mucosa of the albino rabbit and rat. Food and Chemical Toxicology 20, 193-196.
60. Klaenhammer, T.R. (1988) Bacteriocins of lactic acid bacteria. Biochimie 70, 337-349.
61. Klebanoff, S.J., Coombs, R.W. (1991a) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. Journal of Experimental Medicine 174, 289-292.
62. 2-generating lactobacilli. The Journal of Infectious Diseases 164, 94-100.
63. Larsson, P.G., Forsum, U. (2005) Bacterial Vaginosis - a disturbed bacterial flora and treatment enigma. Acta Pathologica, Microbiologica et Immunologica Scandinavica 113, 305-316.
64. Leistner, L. (2000) Basic aspects of food preservation by hurdle technology. International Journal of Food Microbiology 55, 181-186.
65. Leitich, H., Bodner-Adler, B., Brunbauer, M., Kaider, A., Egarter, C., Husselein, P. (2003) Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. American Journal of Obstetrics and Gynecology 189, 139-147.
66. Li, J., Aroutcheva, A.A., Faro, S., Chikindas, M.L. (2005) Mode of action of lactocin 160, a bacteriocin from vaginal Lactobacillus rhamnosus. Infectious Diseases in Obstetrics and Gynecology 13, 135-140.
67. Ling, Z.D., Chang, Q., Lipton, J.W., Tong, C.W., Landers, T.M., Carvey, P.M. (2004) Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124, 619-628.
68. Maizel, J.V., Burkhardt, H.J., Mitchell, H.K. (1964) Avenacin, an antimicrobial substance isolated from Avena sativa. I. Isolation and antimicrobial activity. Biochemistry 3, 424-426.
69. Mandal, P., Sinha Babu S.P., Mandal, N.C. (2005) Antimicrobial activity of saponins from Acacia auriculiformis. Fitoterapia 76, 462-465.
70. Marrazzo, J.M., Cook, R.L., Wiesenfeld, H.C., Murray, P.J., Busse, B., Krohn, M., Hillier S.L. (2006) Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. Journal of Women's Health 15, 1053-1060.
71. Martin, L.S., McDougal, J.S., Loskoski, S.L. (1985) Disinfection and inactivation of the human T lymphotropic virus type III/ lymphadenopathy-associated virus. The Journal of Infectious Diseases 152, 400-403.
72. Martin, H.L., Richardson, B.A., Nyange, P.M., Lavreys, L., Hillier, S.L., Chohan, B., Mandaliya, K., Ndinya-Achola, J.O., Bwayo, J., Kreiss, J. (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. The Journal of Infectious Diseases 180, 1863-1868.
73. McEntire, J.C., Montvile, T.J., Chikindas, M.L. (2003) Synergy between nisin and select lactates against Listeria monocytogenes is due to the metal cations. Journal of Food Protection 66, 1631-1636.
74. McGroarty, J.A., Reid, G. (1988) Detection of a Lactobacillus substance that inhibits Escherichia coli. Canadian Journal of Microbiology 34, 974-978.
75. McLean, N.W., McGroarty, J.A. (1996) Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by lactobacilli in vitro. Applied and Environmental Microbiology 62, 1089-1092.
76. McLean, N.W., Rosenstein, I.J. (2000) Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. Journal of Medical Microbiology 49, 543-552.
77. Mijac, V.D., Dukic, S.V., Opavski, N., Dukic, M.K., Ranin, L.T. (2006) Hydrogen peroxide producing lactobacilli in women with vaginal infections. European Journal of Obstetrics, Gynecology and Reproductive Biology 129, 69-76.
78. Najjar, M.B., Kashtanov, D., Chikindas, M.L. (2007) -̇poly-Llysine and nisin A act synergistically against Gram-positive foodborne pathogens Bacillus cereus and Listeria monocytogenes. Letters in Applied Microbiology 45, 13-18.
79. Nissen-Meyer, J., Nes, I.F. (1997) Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis and mechanism of action. Archives of Microbiology 167, 67-77.
80. Nykänen, A., Weckman, K., Lapveteläinen, A. (2000) Synergistic inhibition of Listeria monocytogenes on cold-smoked rainbow trout by nisin and sodium lactate. International Journal of Food Microbiology 61 (1):63-72.
81. Ocana, V.S., Pesce de Ruiz Holquado, A.A., Nader-Macias, M.E. (1999) Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Applied and Environmental Microbiology 65, 5631-5635.
82. Ojha, P., Maikhuri, J.P., Gupta, G. (2003) Effect of spermicides on Lactobacillus acidophilus in vitro-nonoxynol-9 vs. Sapindus saponins. Contraception 68, 135-138.
83. Okkers, D.J., Dicks, L.M.T., Silvester, M., Joubert, J.J., Odendaal, H.J. (1999) Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans. Journal of Applied Microbiology 87, 726-734.
84. Onderdonk, A.B. (2006) Probiotics for women's health. Journal of Clinical Gastroenterology 40, 256-259.
85. Oscáriz, J.C., Pisabarro, A.G. (2001) Classification and mode of action of membrane-active bacteriocins produced by Gram-positive bacteria. International Journal of Microbiology 4, 13-19.
86. Othman, M., Neilson, J., Alfirevic, Z. (2007) Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews 1, CD005941.
87. Paavonen, J., Mangioni, C., Martin, M.A., Wajszczuk, C.P. (2000) Vaginal cindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstetrics & Gynecology 96, 256-260.
88. Pybus, V., Onderdonk, A.B. (1999) Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes and Infection 1, 285-292.
89. Reddy, K.V., Aranha, C., Gupta, S.M., Yedery, R.D. (2004) Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 128, 117-126.
90. Reid, G. (1999) The scientific basis fbr probiotic strains of Lactobacillus. Applied and Environmental Microbiology 65, 3763-3766.
91. Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J., Henning, B. (2001) Oral probiotics can resolve urogenital infections. FEMS Immunology and Medical Microbiology 30, 49-52.
92. Reid, G., Burton, J. (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes and Infection 4, 319-324.
93. Reid, G., Bocking, A. (2003a) The potential for probiotics to prevent bacterial vaginosis and preterm labor. American Journal of Obstetrics and Gynecology 189, 1202-1208.
94. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., Bruce, A.W. (2003b) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 35, 131-134.
95. Rönnqvist, P.D.J., Forsgren-Brusk, U.B., Hakansson, E.E.G. (2006) Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstetricia et Gynecologica Scandinavica 85, 726-735.
96. Sablone, E., Contreras, B., Vandamme, E. (2000) Antimicrobial peptides of lactic acid bacteria: Mode of action, genetics and biosynthesis. Advances in Biochemical Engineering/Biotechnology 68, 21-60
97. Saunders, S., Bocking, A., Challis, J., Reid, G. (2007) Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids and Surfaces B: Biointerfaces 55, 138-142.
98. Schwebke, J.R., Desmond, R. (2005) Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sexually Transmitted Diseases 32, 654-658.
99. Scirpa, P., Scambia, G., Masciullo, V., Battaglia, F., Foti, E., Lopez, R. Villa, P., Malecore, M., Mancuso, S. (1999) A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by human papillomavirus. Minerva Ginecologica 51, 255-260.
100. Sewankambo, N., Gray, R.H., Wawer, M.J., Paxton, L., McNaim, D., Wabwirre-Mangen, F., Serwadda, D., Li, C., Kiwanuka N., Hillier, S.L., Rabe, L., Gaydos, C.A., Quinn, T.C., Konde-Lule, J. (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350, 546-550.
101. Sha, B.E., Zariffard, M.R., Wang, Q.J., Chen, H.Y., Bremer, J., Cohen, M.H., Spear, G.T. (2005) Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. The Journal of Infectious Diseases 191, 25-32.
102. Shih, I.L., Shen, M.H., Van, Y.T. (2006) Microbial synthesis of poly(epsilon-lysine) and its various applications. Bioresource Technology 97, 1148-1159.
103. Shima, S., Matsuoka, H., Iwamoto, T., Sakai, H. (1984) Antimicrobial action of ε-poly-L-lysine. The Journal of Antibiotics (Tokyo) 37, 1449-1455.
104. Silva, M., Jacobus, N.V., Deneke, C., Gorbach, S.L. (1987) Antimicrobial substance from a human Lactobacillus strain. Antimicrobial Agents and Chemotherapy 31, 1231-1233.
105. Simoes, J., Aroutcheva, A., Shott, S., Faro, S. (2001) Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infectious Diseases in Obstetrics and Gynecology 9, 41-46.
106. Simoes, J.A., Bahamondes, L.G., Camargo, R.P.S., Alves, V.M.N., Zaneveld, L.J.D., Wallet, D.P., Schwartz, J., Callahan, M.M., Mauck, C.K. (2006) A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. British Journal of Clinical Pharmacology 61(2), 211-217.
107. Skarin, A., Sylwan, J. (1986) Vaginal lactobacilli inhibiting growth of Gardnerella vaginalis, Mobiluncus and other bacterial species cultured from vaginal content of women with bacterial vaginosis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 94, 399-403.
108. Sobel, J.D. (1999) Is There a Protective Role for Vaginal Flora? Current Infectious Disease Reports 1, 379-383.
109. Stevens, K.A., Sheldon, B.W., Klpaes, N.A., Klaenhammer, T.R. (1991) Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Applied and Environmental Microbiology 57, 3613-3615.
110. Strus, M., Brzychczy-Wloch, M., Gosiewski, T., Kochan, P., Heczko, P.B. (2006) The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS Immunology and Medical Microbiology 48, 56-63.
111. Svare, J.A., Schmidt, H., Hansen, B.B., Lose, G. (2006) Bacterial vaginosss in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birth weight and prenatal infections. British Journal of Obstetrics and Gynaecology 113, 1419-1425.
112. Taha, T.E., Hoover, D.R., Dallabetta, G.A., Kumwenda, N.I., Mtimavalye, L.A., Yang, L.P., Liomba, G.N., Broadhead, R.L., Chiphangwi, J.D., Miotti, P.G. (1998) Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12, 1699-1706.
113. Tansupasiri, A., Puangsricharern, A., Itti-arwachakul, A., Asavapiriyanont, S. (2005) Satisfaction and tolerability of combination of lactoserum and lactic acid on the external genitalia in Thai women. Journal of the Medical Association of Thailand 88, 1753-1757.
114. Tarantino, L.M. (2004) GRAS Notice No. GRN 000135. CFSAN/Office of Food Additive Safety. Agency Response Letter.
115. Todorov, S.D., Danova, S.T., Van Reenen, C.A., Meincken, M., Dinkova, G., Ivanova, I.V., Dicks L. M.T. (2006) Characterization of bacteriocin HV219, produced by Lactococcus lactis subsp. lactis HV219 isolated from human vaginal secretions. Journal of Basic Microbiology 46, 226-238.
116. Uehara, S., Monden, K., Nomoto, K., Seno, Y., Kariyama, R., Kumon, H. (2006) A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. International Journal of Antimicrobial Agents 28, S30-34.
117. Uni-Sankyo December 12 2006: http://www.pubergen.com/myconip.htm
118. Urakubo, A., Jarskog, L.F., Lieberman, J.A., Gilmore, J.H. (2001) Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophrenia Research 47, 27-36.
119. Valore, E.V., Park, C.H., Igreti, S.L., Ganz, T. (2002) Antimicrobial components of vaginal fluid. American Journal of Obstetrics and Gynecology 187, 561-568.
120. Valore, E.V., Wiley, D.J., Ganz, T. (2006) Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infection and Immunity 74, 5693-5702.
121. Voravuthikunchai, S.P., Bilasoi, S., Supamala, O. (2006) Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe 12, 221-226.
122. webMD October 15, 2006: http://www.webmd.com/hw/std/hw53060.asp
123. 2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. Journal of Clinical Microbiology 42, 713-717.
124. Winceslaus, S.J., Calver, G. (1996) Recurrent bacterial vaginosis-an old approach to a new problem. The International Journal of STD & AIDS 7, 284-287.
125. World Health Organization, Food Safety Department. (2005) Modern food biotechnology, human health and development: an evidence based study. p.9
126. Yoshida, T., Nagasawa, T. (2003) -̇poly-L-lysine: microbial production, biodegradation and application potential. Applied Microbiology Biotechnology 62, 21-26.
127. Wrong diagnosis, January 20, 2008; http://www.wrongdiagnosis.com/b/ bacterial_vaginosis/statscountry.htm